Clinical efficacy of IMRT combined with late course stereotactic body radiotherapy for local middle-late stage non-small cell lung cancer

Luo Qian; Wang Ying; Wu Yongzhong; Zhou wei; Liu Xianfeng

doi:10.13406/j.cnki.cyxb.001101

您当前的位置：

首页 >

文章列表页 >

Clinical efficacy of IMRT combined with late course stereotactic body radiotherapy for local middle-late stage non-small cell lung cancer

更新时间：2024-01-17

- Clinical efficacy of IMRT combined with late course stereotactic body radiotherapy for local middle-late stage non-small cell lung cancer
- Journal of Chongqing Medical University Vol. 42, Issue 1, Pages: 32-36(2017)
- 作者机构：
  
  重庆市肿瘤研究所/医院/癌症中心放疗科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.001101
  CLC： R734.2;R730.55
- Published：2017，
扫描看全文
[1]罗茜,王颖,吴永忠,周伟,柳先锋.IMRT联合后程立体定向放射治疗局部中晚期非小细胞肺癌的近期疗效分析[J].重庆医科大学学报,2017,42(01):32-36.

Luo Qian, Wang Ying, Wu Yongzhong, et al. Clinical efficacy of IMRT combined with late course stereotactic body radiotherapy for local middle-late stage non-small cell lung cancer. [J]. Journal of Chongqing Medical University 42(1):32-36(2017)
[1]罗茜,王颖,吴永忠,周伟,柳先锋.IMRT联合后程立体定向放射治疗局部中晚期非小细胞肺癌的近期疗效分析[J].重庆医科大学学报,2017,42(01):32-36. DOI： 10.13406/j.cnki.cyxb.001101.

Luo Qian, Wang Ying, Wu Yongzhong, et al. Clinical efficacy of IMRT combined with late course stereotactic body radiotherapy for local middle-late stage non-small cell lung cancer. [J]. Journal of Chongqing Medical University 42(1):32-36(2017) DOI： 10.13406/j.cnki.cyxb.001101.

摘要

目的:比较适形调强放射治疗（intensity modified radiotherapy

IMRT）联合后程立体定向放射治疗（stereotactic body radiotherapy

SBRT）与单纯IMRT治疗局部中晚期非小细胞肺癌的疗效。方法:将90例局部中晚期非小细胞肺癌（non-small cell lung cancer

NSCLC）患者随机分成试验组和对照组

各45例。试验组采用IMRT联合后程SBRT

先行IMRT

常规分割剂量至50 Gy/5周

再采用SBRT推量17.5 Gy/1周;对照组采用IMRT

常规分割剂量至70 Gy/7周。在放疗结束3

个月后行肺部增强CT检查

采用实体瘤治疗疗效评价标准（response evaluation criteria in solid tumors

RECIST）评价完全缓解率（complete remission

CR）和部分缓解率（partial remission

PR）。按照放射治疗肿瘤学组（radiation therapy oncology group

RTOG）标准评价正常组织急性反应。结果:试验组治疗的有效率（CR+PR）明显高于对照组

分别为84.44%和66.67%

2组之间有统计学差异（P=0.05）。试验组的放射性肺炎发生率要低于对照组

分别为4.44%和13.33%

但2组之间无统计学差异（P=0.138）。2组放射性食管炎发生率分别为44.44%和48.89%

2组之间亦无统计学差异（P=0.822）。放射性脊髓炎均未发生。结论:IMRT联合后程立体定向放射治疗局部中晚期非小细胞肺癌安全有效

疗效优于单纯IMRT放疗

且引起的急性组织反应少

故临床上值得推广应用。

Abstract

Objective:To compare the clinical efficiency of intensity modified radiotherapy(IMRT)/stereotactic body radiotherapy(SBRT)with that of IMRT in the treatment of local middle-late stage non-small cell lung cancer. Methods:Totally 90 patients with local middle-late stage non-small cell lung cancer(NSCLC)were randomly divided into two groups:experimental group(45 patients)and control group(45 patients). The experimental group was firstly treated by IMRT plan(conventional fractionation to a total dose of DT 50 Gy/5 weeks)and then followed by SBRT plan(hypo-fractionation to a total dose of DT 17.5 Gy/1 weeks).The control group was treated by mere IMRT plan(conventional fractionation to a total dose of DT 70 Gy/7 weeks). Lung enhanced CT scanning were performed 3 to 6 months after radiotherapy. Complete remission(CR) and partial remission(PR) rates were assessed according to the RECIST criterion. Acute inflammatory reaction of normal tissue were assessed according to the RTOG criterion. Results:The CR and PR rates of experimental group were remarkably higher than those of control group

84.44% and 66.67%

respectively. There were statistically significant differences between the two groups(P=0.05). The incidence rate of radioactive pneumonia in experimental group was inferior to that of control group

4.44% and 13.33%

respectively. The incidence rates of radioactive esophagitis were 44.44%and 48.89%

respectively. No significant difference was found between two groups regarding incidence rate of radioactive pneumonia(P=0.138)and radioactive esophagitis(P=0.822). No radioactive myelitis were found in either groups. Conclusions:Compared with IMRT

IMRT/SBRT is safer and more effective. And the acute tissue side reactions rarely occurred. Therefore

it could be extended and widely used in clinical work in the future.

关键词

后程立体定向放射治疗适形调强放射治疗非小细胞肺癌放射治疗

Keywords

stereotactic body radiotherapyintensity modified radiotherapynon-small cell lung cancerradiotherapy

references

Views

113

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advances in immunotherapy in EGFR-mutated non-small cell lung cancer

Efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with docetaxel monotherapy in previously treated advanced non-small-cell lung cancer:a Meta-analysis

Long non-coding RNA MIR155HG promotes proliferation,migration and invasion of A549 human lung cancer cells

Neoplasms oligometastasis and progress in its therapeutic strategies

Association of OCT4 positive expression with clinic-pathological characteristics in non-small cell lung cancer: a Meta-analysis

Related Author

Wei Kunchen

Wu Junfeng

Tang Hao

Yang Yingqing

Jiang Depeng

Jiang Youfan

Sun Bailin

Yang Nengxue

Related Institution

Department of Respiratory and Critical Care Medicine,Shanghai Changzheng Hospital

Beijing Garrison District Haidian 40th Separation Cadre Retreat

Department of Respiratory Diseases,the Second Affiliated Hospital,Chongqing Medical University

Department of Internal Medicine,Chongqing Jianshe Hospital

Department of Radiotherapy,The First Affiliated Hospital of Bengbu Medical College

⁰